Literature DB >> 32119093

Effect of Home Blood Pressure Monitoring via a Smartphone Hypertension Coaching Application or Tracking Application on Adults With Uncontrolled Hypertension: A Randomized Clinical Trial.

Stephen D Persell1,2, Yaw A Peprah1, Dawid Lipiszko1, Ji Young Lee1, Jim J Li3, Jody D Ciolino4, Kunal N Karmali5, Hironori Sato3.   

Abstract

Importance: Mobile applications (apps) may help improve hypertension self-management. Objective: To investigate the effect of an artificial intelligence smartphone coaching app to promote home monitoring and hypertension-related behaviors on systolic blood pressure level compared with a blood pressure tracking app. Design, Setting, and Participants: This was a 2-group, open, randomized clinical trial. Participants with uncontrolled hypertension were recruited in 2016 and 2017 and were followed up for 6 months. Data analysis was performed from April 2019 to December 2019. Interventions: Intervention group participants received a smartphone coaching app to promote home monitoring and behavioral changes associated with hypertension self-management plus a home blood pressure monitor. Control participants received a blood pressure tracking app plus a home blood pressure monitor. Main Outcomes and Measures: The primary study outcome was systolic blood pressure at 6 months. Secondary outcomes included self-reported antihypertensive medication adherence, home monitoring and self-management practices, measures of self-efficacy associated with blood pressure, weight, and self-reported health behaviors.
Results: There were 333 participants randomized, and 297 completed the follow-up assessment. Among the participants who completed the study, the mean (SD) age was 58.9 (12.8) years, 182 (61.3%) were women, and 103 (34.7%) were black. Baseline mean (SD) systolic blood pressure was 140.6 (12.2) mm Hg among intervention participants and 141.8 (13.4) mm Hg among control participants. After 6 months, the corresponding mean (SD) systolic blood pressures were 132.3 (15.0) mm Hg and 135.0 (13.9) mm Hg, with a between-group adjusted difference of -2.0 mm Hg (95% CI, -4.9 mm Hg to 0.8 mm Hg; P = .16). At 6 months, self-confidence in controlling blood pressure was greater in the intervention group (0.36 point on a 5-point scale; 95% CI, 0.18 point to 0.54 point; P < .001). There were no significant differences between the 2 groups in other secondary outcomes. The adjusted difference in self-reported physical activity was 26.7 minutes per week (95% CI, -5.4 minutes per week to 58.8 minutes per week; P = .10). Subgroup analysis raised the possibility that intervention effects differed by age. Conclusions and Relevance: Among individuals with uncontrolled hypertension, those randomized to a smartphone coaching app plus home monitor had similar systolic blood pressure compared with those who received a blood pressure tracking app plus home monitor. Given the direction of the difference in systolic blood pressure between groups and the possibility for differences in treatment effects across subgroups, future studies are warranted. Trial Registration: ClinicalTrials.gov Identifier: NCT03288142.

Entities:  

Year:  2020        PMID: 32119093     DOI: 10.1001/jamanetworkopen.2020.0255

Source DB:  PubMed          Journal:  JAMA Netw Open        ISSN: 2574-3805


  26 in total

Review 1.  mHealth Technology and CVD Risk Reduction.

Authors:  Maan Isabella Cajita; Yaguang Zheng; Jacob Kigo Kariuki; Karen M Vuckovic; Lora E Burke
Journal:  Curr Atheroscler Rep       Date:  2021-05-13       Impact factor: 5.113

Review 2.  [Telemonitoring and eHealth for arterial hypertension : Status quo and perspectives].

Authors:  C Beger; H Haller; F P Limbourg
Journal:  Internist (Berl)       Date:  2021-02-12       Impact factor: 0.743

Review 3.  Behaviour change techniques in cardiovascular disease smartphone apps to improve physical activity and sedentary behaviour: Systematic review and meta-regression.

Authors:  Kacie Patterson; Rachel Davey; Richard Keegan; Brea Kunstler; Andrew Woodward; Nicole Freene
Journal:  Int J Behav Nutr Phys Act       Date:  2022-07-07       Impact factor: 8.915

Review 4.  Machine Learning in Health Promotion and Behavioral Change: Scoping Review.

Authors:  Yong Shian Goh; Jenna Qing Yun Ow Yong; Bernice Qian Hui Chee; Jonathan Han Loong Kuek; Cyrus Su Hui Ho
Journal:  J Med Internet Res       Date:  2022-06-02       Impact factor: 7.076

5.  Self-care of hypertension of older adults during COVID-19 lockdown period: a randomized controlled trial.

Authors:  Khitam Alsaqer; Hatice Bebis
Journal:  Clin Hypertens       Date:  2022-07-15

6.  Epidemiology of arterial hypertension in Tunisia: Hammam Sousse Sahloul Heart Study (HSHS).

Authors:  Aicha Hamoudi; Asma Ben Abdelaziz; Sarra Melki; Donia Ben Hassine; Nabila Ben Rejeb; Asma Omezzine; Ali Bouslama; Ahmed Ben Abdelaziz
Journal:  Tunis Med       Date:  2022 fevrier

7.  Pilot Results of a Digital Hypertension Self-management Program Among Adults With Excess Body Weight: Single-Arm Nonrandomized Trial.

Authors:  Folasade Wilson-Anumudu; Ryan Quan; Christian Cerrada; Jessie Juusola; Cynthia Castro Sweet; Carolyn Bradner Jasik; Michael Turken
Journal:  JMIR Form Res       Date:  2022-03-30

Review 8.  The Effect of Smartphone App-Based Interventions for Patients With Hypertension: Systematic Review and Meta-Analysis.

Authors:  Hongxuan Xu; Huanyu Long
Journal:  JMIR Mhealth Uhealth       Date:  2020-10-19       Impact factor: 4.773

9.  Development of a Digital Lifestyle Modification Intervention for Use after Transient Ischaemic Attack or Minor Stroke: A Person-Based Approach.

Authors:  Neil Heron; Seán R O'Connor; Frank Kee; David R Thompson; Neil Anderson; David Cutting; Margaret E Cupples; Michael Donnelly
Journal:  Int J Environ Res Public Health       Date:  2021-05-02       Impact factor: 3.390

10.  Hypertension prevalence in the All of Us Research Program among groups traditionally underrepresented in medical research.

Authors:  Paulette D Chandler; Cheryl R Clark; Guohai Zhou; Nyia L Noel; Confidence Achilike; Lizette Mendez; Andrea H Ramirez; Roxana Loperena-Cortes; Kelsey Mayo; Elizabeth Cohn; Lucila Ohno-Machado; Eric Boerwinkle; Mine Cicek; Jun Qian; Sheri Schully; Francis Ratsimbazafy; Stephen Mockrin; Kelly Gebo; Julien J Dedier; Shawn N Murphy; Jordan W Smoller; Elizabeth W Karlson
Journal:  Sci Rep       Date:  2021-06-22       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.